Elisabetta Poluzzi

发表

Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation

Nicholas Moore, Francesco Salvo, Emanuel Raschi, 2014, European Journal of Clinical Pharmacology.

PV-OWL — Pharmacovigilance surveillance through semantic web-based platform for continuous and integrated monitoring of drug-related adverse effects in open data sources and social media

Sonia Bergamaschi, Mirko Orsini, Elisabetta Poluzzi, 2017, 2017 IEEE 3rd International Forum on Research and Technologies for Society and Industry (RTSI).

15 - medicinali, iter regolatorio e tipi di studio

Elisabetta Poluzzi, 2016 .

24 - dispensazione, rimborso, equivalenti, off-label

Elisabetta Poluzzi, 2015 .

Drug‐induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)

Emanuel Raschi, Ugo Moretti, Elisabetta Poluzzi, 2009, Pharmacoepidemiology and drug safety.

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting

Elisabetta Poluzzi, Carlo Piccinni, Giulio Marchesini, 2011, Diabetes Care.

Initial treatment of hypertension and adherence to therapy in general practice in Italy

Fabrizio Ponti, Elisabetta Poluzzi, F. Ponti, 2005, European Journal of Clinical Pharmacology.

Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes

Maurizio Recanatini, Fabrizio Ponti, Elisabetta Poluzzi, 2002, Drug safety.

Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database

Fabrizio De Ponti, Emanuel Raschi, Ugo Moretti, 2013 .

Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS)

Fabrizio De Ponti, Emanuel Raschi, Elisabetta Poluzzi, 2012 .

Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database

Elisabetta Poluzzi, Carlo Piccinni, Giuseppe Roberto, 2014, Cephalalgia : an international journal of headache.

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Fabrizio De Ponti, Matteo Masetti, Maurizio Recanatini, 2005, Medicinal research reviews.

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

Elisabetta Poluzzi, E. Poluzzi, F. De Ponti, 2001, European Journal of Clinical Pharmacology.